Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Trop Anim Health Prod ; 56(1): 8, 2023 Dec 11.
Article in English | MEDLINE | ID: mdl-38072881

ABSTRACT

The purpose of the present experiment was to explore the therapeutic effect of the crude fruit juice of Citrus aurantifolia (CAJ) on Eimeria tenella disorder in chickens. One hundred twenty 3-week-old Ross 308 broilers of equal sexes were assigned to six experimental groups of 20 birds each. Groups A, B, C, D, and E were experimentally infected with 20,000 sporulated Eimeria tenella oocysts. Broilers in groups A, B, and C were infected and allocated to three treatment-graded doses of C. aurantifolia fruit juice (20, 10, and 5 mL/kg body weight, respectively) which were administered orally for 7 consecutive days of the trial. Group D was infected and treated with a reference drug, Amprolium 1.5 g/L of drinking water (positive control), group E served as infected-untreated control, and group F was uninfected and non-treated (negative control). Oocysts per gram of feces were counted using the McMaster counting device, weight gain was calculated, and blood samples from each experimental group were collected on days 0, 7, 14, 21, and 28 post-infection for hematological evaluation. Results revealed that medication of broilers with C. aurantifolia fruit juice dose-dependently increased body weight, improved cecal lesion, decreased the E. tenella oocyst production rate, and significantly (P<0.05) increased the PCV of the infected broilers. C. aurantifolia provided valuable therapeutic effects against E. tenella-induced coccidiosis in broiler chickens. The plant fruit juice should be further validated to explore the vital compounds responsible for the anticoccidial efficacy.


Subject(s)
Citrus , Coccidiosis , Eimeria tenella , Poultry Diseases , Animals , Chickens , Coccidiosis/drug therapy , Coccidiosis/pathology , Coccidiosis/veterinary , Oocysts , Poultry Diseases/drug therapy , Poultry Diseases/pathology , Weight Gain , Male , Female
2.
Acta Parasitol ; 67(1): 391-402, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34625859

ABSTRACT

PURPOSE: Dogs are of immense social, psychological and economic importance in Nigeria and are severely affected by African trypanosomosis. However, the prevalence of canine African trypanosomosis (CAT) in Nigeria is underreported and the identification of the parasites relies mostly on basic morphological characteristics under the microscope, which could be misleading. The present study was carried out to determine the prevalence and characterize trypanosomes isolated from dogs in South east Nigeria. METHODS: A cross-sectional survey was carried out to determine the prevalence and molecular identification of trypanosomes in dogs in Enugu North Senatorial Zone (ENSZ), South east Nigeria. Dogs (n = 450) were randomly sampled, their blood collected and some characteristics such as sex, breed, sampling location, season and age duly noted. The blood samples were screened for trypanosomosis using standard trypanosome detection techniques. Trypanosome-positive blood samples were spotted on FTA® cards for molecular identification using nested Tubulin-PCR, ITS-PCR, TgsGP-PCR, and DNA sequencing. Some hematological parameters of the dogs such as packed cell volume (PCV), total leucocyte count (TLC), red blood cell count (RBC) were also determined. RESULTS: Of the 450 dogs sampled, 51 dogs were positive for trypanosomes with a prevalence rate of 11.3% (95% CI = 0.087-0.146). Trypanosoma brucei was the predominant trypanosome species infecting dogs in the study area. T. congolense, T. evansi, and T. vivax were also identified. The prevalence of canine trypanosomosis was significantly associated with season (χ2 = 13.821, df = 1, P = 0.0001) and the sampling location (χ2 = 6.900, df = 2, P = 0.032) while sex, breed, and age were not. The PCV and RBC of the infected dogs were significantly lower (p < 0.0001) than those of the uninfected dogs. CONCLUSIONS: CAT due to T. brucei is very prevalent in Enugu North Senatorial Zone, South east Nigeria and is associated with hematological changes. Our study also detected T. vivax in dogs in South east Nigeria which appears to be the first report of T. vivax in a dog in Nigeria.


Subject(s)
Trypanosoma , Trypanosomiasis, African , Animals , Cross-Sectional Studies , Dogs , Nigeria/epidemiology , Prevalence , Trypanosoma/genetics , Trypanosomiasis, African/epidemiology
3.
Parasitol Res ; 121(1): 423-431, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34746978

ABSTRACT

African animal trypanosomosis is an important wasting and endemic protozoan disease causing morbidities and mortalities in animals in the sub-Saharan Africa. Currently, chemotherapy is the widely used method of African animal trypanosomosis control, especially in dogs in the sub-Saharan Africa. However, their efficacy is threatened by the emergence of drug-resistant trypanosomes owing to their extensive use and misuse over several decades amongst other factors. Thus, this study focused on the trypanocidal sensitivity and characterization of Trypanosoma species isolated from dogs in Enugu North Senatorial Zone (ENSZ), Southeastern Nigeria. Trypanosoma brucei (n = 44) and T. congolense (n = 4) isolated from naturally infected dogs in ENSZ, Southeastern Nigeria, between January and August 2016 were subjected to single dose test to assess their sensitivity to diminazene aceturate (DA) and isometamidium chloride (ISM). Subsequently, DA and multidrug-resistant isolates were further subjected to DA multi-dose test and CD50 was determined and was used to characterize the drug-resistant trypanosomes. Clones were derived from a randomly selected multidrug-resistant isolate and their sensitivity also assessed. 100% and 83.3% of T. congolense and T. brucei respectively were resistant to the trypanocides. Amongst the drug-resistant isolates, 50%, 16.7%, and 33.3% were resistant to DA, ISM, and both trypanocides respectively with CD50 ranging between 11 and 32.34 mg/kg. Drug-resistant trypanosomes were characterized into highly resistant (CD50 = 11-24.99 mg/kg) and very highly resistant (CD50 = > 25 mg/kg) trypanosome isolates. Clones also expressed high levels of resistance to both DA and ISM with CD50 values between 35.58 and 38.85 mg/kg. Trypanocidal resistance was, thus, confirmed and appears to be widespread in dogs in ENSZ, Southeastern Nigeria. The adoption of an integrated trypanosomosis control strategy in ENSZ is most desirous.


Subject(s)
Pharmaceutical Preparations , Trypanocidal Agents , Trypanosoma congolense , Trypanosomiasis, African , Animals , Diminazene , Dogs , Drug Resistance , Nigeria , Trypanocidal Agents/pharmacology , Trypanosomiasis, African/drug therapy
4.
Vet Parasitol ; 282: 109138, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32474296

ABSTRACT

Azithromycin and diminazene aceturate combination therapy in experimental multidrug-resistant Trypanosoma brucei brucei infection in albino rats was evaluated. A total of forty-five female albino rats were used. These rats were randomly assigned to nine groups of five rats each. Group 1 was the uninfected-untreated group while groups 2 - 6 were infected with 1 × 106 trypanosomes suspended in 0.3 ml of normal saline intraperitoneally. Following infection and parasitaemia, group 2 was untreated while group 3 was treated once with 7 mg/kg diminazene aceturate. Groups 4 - 6 were treated with 10, 20 and 30 mg/kg azithromycin respectively for 7 days. Groups 7 - 9 were treated with combination of 7 mg/kg diminazene aceturate (DA) once and 10, 20 and 30 mg/kg azithromycin (AZT) respectively for 7 days. Level of parasitaemia, haematological indices (packed cell volume, total erythrocyte count, total leukocyte count, haemoglobin concentration, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration), survivability, body weight and rectal temperature were used to assess the effectiveness of the combination therapy. A significant reduction in parasitaemia levels was observed in the DA-treated group and AZT-treated group 6 while clearance of parasitaemia was observed in the DA-AZT treated groups 7 - 9 for periods between 1 and 5 days post treatment. The haematological indices and survivability of the DA-AZT treated groups were better than the DA-treated group despite the relapse recorded in those groups. One rat each in the DA-AZT combination groups survived till the end of the experiment. In conclusion, the DA-AZT combination treatment can be used as a possible adjunct to DA in the treatment of multidrug-resistant T. brucei brucei. The combination also enhanced survivability and decreased the effect of the disease in rats.


Subject(s)
Azithromycin/pharmacology , Diminazene/analogs & derivatives , Drug Resistance, Multiple , Trypanocidal Agents/pharmacology , Trypanosoma brucei brucei/drug effects , Animals , Diminazene/pharmacology , Drug Therapy, Combination/veterinary , Female , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...